Automated determination of serum α1-Antitrypsin by antitryptic activity measurement

Clinical Chemistry

Volumn 55, Issue 3, 2009, Pages 513-518

  Roche, Denis ^a   Mesner, Alexandra ^a   Al Nakib, Malik ^a   Leonard, Frederic ^a   Beaune, Philippe ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; GELATIN SUCCINATE; TRINITROBENZENESULFONIC ACID; TRYPSIN INHIBITOR;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; AUTOANALYZER; BLOOD SAMPLING; CHEMICAL REACTION; CLINICAL EVALUATION; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; IMMUNOASSAY; LABORATORY AUTOMATION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; REFERENCE VALUE; RELIABILITY; VALIDATION STUDY; BLOOD; MIDDLE AGED; STATISTICAL MODEL;

ADULT; ALPHA 1-ANTITRYPSIN; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; TRYPSIN INHIBITORS;

EID: 62149151728     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2008.117002     Document Type: Article

References (21)

1. Mann KG, Brummel K, Butenas S. What is all that thrombin for? J Thromb Haemost 2003;1: 1504-14.
2. Hartert H. Blutgerinnungsstudien mit der Thom- belastographie, einem neuen Untersuchungsver- fahren. Klin Wochenschr 1948;26:577-83.
3. Hemker HC, Béguin S. Thrombin generation: old wine into new wineskins. Thromb Haemost 2003; 90:764-5.
4. Pitney WR, Dacie J. A simple method of studying the generation of thrombin in recalcified plasma. J Clin Pathol 1953;6:9-13.
5. Hemker HC, Wielders S, Kessels H, Béguin S. Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential. Thromb Haemost 1993;70: 617-24.
6. Hemker HC, Giesen PL, Ramjee M, Wagenvoord R, Béguin S. The thrombogram: monitoring thrombin generation in platelet-rich plasma. Thromb Haemost 2000;83:589-91.
7. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smed E, Wagenvoord R, et al. The Calibrated Automated Thrombogram (CAT): a universal rou- tine test for hyper- and hypocoagulability. Patho- physiol Haemost Thromb 2002;32:249-53.
8. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, et al. Calibrated auto- mated thrombin generation measurement in clot- ting plasma. Pathophysiol Haemost Thromb 2003;33:4-15.
9. Bard AJ, Faulkner LR. Electrochemical methods: fundamentals and applications. New York: Wiley & Sons; 1980. 718 p.
10. D'Orazio P. Biosensors in clinical chemistry. Clin Chim Acta 2003;334:41-69.
11. Moresi A. Development of an amperometric Bio- sensor for thrombin. [Dissertation]. Basel (Switzerland): University of Basel, 2001:150pp.
12. Frenkel EJ, Haeberli A, Moresi A, inventors; Asu- lab, assignee. Electrochemical system for deter- mining blood coagulation time. US Patent 6,352,630. 2002 Mar 5.
13. Ludin C, Wikstroem P, Svendsen LG, Schulze A, inventors; Pentapharm, assignee. Oligopeptide derivatives for the electrochemical measurement of protease activity. US Patent 6,495,336. 2002 Dec 17.
14. Thurlemann C, Haeberli A, Frenkel EJ, inventors; Asulab, assignee. System for differential determi- nation of a proteolytic enzyme level in a bodily fluid. US Patent Application Publication 2007/0009982 A1. 2007 Jan 11.
15. Hron G, Kollars M, Binder BR, Eichinger S, Kyrle PA. Identification of patients at low risk for re- current venous thromboembolism by measur- ing thrombin generation. JAMA 2006;296:397-402.
16. Calatzis A, Reininger AJ, Spannagl A, Schramm W. Rapid and automated quantification of the kinetics of thrombin formation using the Throm- bin Dynamics Test (TDT) [Abstract]. J Thromb Haemost 2003;1 Suppl 1:P1589.
17. Udenfried S. Fluorescence assay in biology and medicine. Volumes 1 and 2. New York: Academic Press; 1962-1969. p. 13, 118 (vol 1); p. 182-5 (vol 2).
18. Thürlemann C. Entwicklung eines Biosensor- Systems für ein Patienten-Selbstmanagement der Behandlung mit Vitamin K-Antagonisten [Disser- tation]. Basel (Switzerland): University of Basel, 2005: 181 pp. http://pages.unibas.ch/diss/2005/DissB-7319.htm (Accessed October 2005).
19. Hézard N, Bouaziz-Borgi L, Remy MG, Nguyen P. Utility of thrombin-generation assay in the screening of factor V G1691A (Leiden) and pro- thrombin G20210A mutations and protein S de- ficiency. Clin Chem 2006;52:665-70.
20. Curvers J, Thomassen MCLGD, Rimmer J, Hamu- lyak K, van der Meer J, Tans G, et al. Effects of hereditary and acquired risk-factors of venous thrombosis on a thrombin generation-based APC resistance test. Thromb Haemost 2002;88:5-11.
21. Camire RM, Kalafatis M, Simioni P, Girolami A, Tracy PB. Platelet-derived factor Va/Va Leiden cofactor activities are sustained on the surface of activated platelets despite the presence of acti- vated protein C. Blood 1998;91:2818-29.